{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:44:40Z","timestamp":1759333480117},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,2,22]],"date-time":"2003-02-22T00:00:00Z","timestamp":1045872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s00105-002-0448-3","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T18:52:54Z","timestamp":1478026374000},"page":"448-452","source":"Crossref","is-referenced-by-count":8,"title":["Pansklerotische Skleroporphyrie nach langj\u00e4hriger Exposition gegen\u00fcber organischen L\u00f6sungsmitteln"],"prefix":"10.1007","volume":"54","author":[{"given":"Theodor","family":"Karamfilov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Buslau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"D\u00fcrr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Weyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,2,22]]},"reference":[{"key":"0448_CR1","doi-asserted-by":"crossref","unstructured":"Fritsch C, Lang K, von Schmiedberg S et al. (1998) Porphyria cutanea tarda. Skin Pharmacol Appl Skin Physiol 11:321\u2013335","DOI":"10.1159\/000029855"},{"key":"0448_CR2","doi-asserted-by":"crossref","unstructured":"K\u00f6stler E, Doss MO (1995) Porphyria cutanea tarda (chronische hepatische Porphyrie). DMW 120:1405\u20131410","DOI":"10.1055\/s-2008-1055492"},{"key":"0448_CR3","doi-asserted-by":"crossref","unstructured":"Elder GH (1991) Porphyria cutanea tarda: pathogenesis in relation to therapy. Curr probl Dermatol 20:91\u201396","DOI":"10.1159\/000420012"},{"key":"0448_CR4","doi-asserted-by":"crossref","unstructured":"Porcel JM, Mirada A, Jordana R, Munoz A (1991) Systemic sclerosis and porphyria cutanea tarda. Ann Rheum Dis 50:270","DOI":"10.1136\/ard.50.4.270-a"},{"key":"0448_CR5","unstructured":"Ocana J, Perez de VargaI, Wilhelmi ML et al. (\u275a) Sclerodermiform porphyria cutanea tarda. Ultrastructural study. Med Cutan Ibero Lat AM 13:157\u2013166"},{"key":"0448_CR6","doi-asserted-by":"crossref","unstructured":"Sigal M, Nahum HD, Crickx B et al. (1990) Porphyria cutanea tarda and scleroderma-chance association or related disease: a case report. Clin Exp Dermatol 15:285\u2013288","DOI":"10.1111\/j.1365-2230.1990.tb02091.x"},{"key":"0448_CR7","doi-asserted-by":"crossref","unstructured":"Doyle JA, Friedman SJ (1983) Porphyria and scleroderma: a clinical and laboratory review. Aust J Dermatol 24:109\u2013114","DOI":"10.1111\/j.1440-0960.1983.tb00266.x"},{"key":"0448_CR8","doi-asserted-by":"crossref","unstructured":"Torinuki W, Kudoh K, Tagami H (1989) Increased mast cell numbers in the sclerotic skin of porphyria cutanea tarda. Dermatologica 178:75\u201378","DOI":"10.1159\/000248396"},{"key":"0448_CR9","doi-asserted-by":"crossref","unstructured":"Mascaro JM (1991) Porphyria cutanea tarda: clinical manifestations. Curr Probl Dermatol 20:79\u201390","DOI":"10.1159\/000420011"},{"key":"0448_CR10","doi-asserted-by":"crossref","unstructured":"Castanet J, Lacour JPH, Perrin C et al. (1994) Sclerodermatous changes revealing porphyria cutanea tarda. Acta Derm Venereol (Stockh) 74:310\u2013311","DOI":"10.2340\/0001555574312313"},{"key":"0448_CR11","unstructured":"Krajnc I, Vizjak A, Hvala A et al. (1998) The significance of histologic analysis of skin lesions in porphyria cutanea tarda. Wien Klin Wochenschr 110\/18:651\u2013654"},{"key":"0448_CR12","doi-asserted-by":"crossref","unstructured":"Varigos G, Schitz JR, Bickers DR (1989) Uroporphyrin I stimulation of collagen biosynthesis in human skin fibroblasts. A unique dark effect of porphyrin. J Clin Invest 69:129\u2013135","DOI":"10.1172\/JCI110423"},{"key":"0448_CR13","unstructured":"Erkrankungen durch Halogenkohlenwasserstoffe. Merkblatt f\u00fcr die \u00e4rztliche Untersuchung. Bek. des BMA v. 29.03.1987"},{"key":"0448_CR14","doi-asserted-by":"crossref","unstructured":"Czirjak L, Pocs E, Szegedi G (1994) Localized scleroderma after exposure to organic solvents. Dermatology 189:399\u2013401","DOI":"10.1159\/000246888"},{"key":"0448_CR15","doi-asserted-by":"crossref","unstructured":"Flindt-Hansen H, Isager H (1987) Scleroderma after occupational exposure to trichlorethylene and trichlorethane. Acta Derm Venereol 67:263\u2013264","DOI":"10.2340\/0001555567263264"},{"key":"0448_CR16","doi-asserted-by":"crossref","unstructured":"Nietert PJ, Sutherland SE, Silver RM et al. (1998) Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheumatism 41:1111\u20131118","DOI":"10.1002\/1529-0131(199806)41:6<1111::AID-ART19>3.0.CO;2-J"},{"key":"0448_CR17","doi-asserted-by":"crossref","unstructured":"Bovenzi M, Barbone F, Betta A et al. (1995) Scleroderma and occupational exposure. Scand J Environ Health 21:289\u2013292","DOI":"10.5271\/sjweh.40"},{"key":"0448_CR18","doi-asserted-by":"crossref","unstructured":"Ishikawa O, Warita S, Tamura A, Miyachi Y (1995) Occupational scleroderma. A 17-year follow-up study. Br J Dermatol 133:786\u2013789","DOI":"10.1111\/j.1365-2133.1995.tb02757.x"},{"key":"0448_CR19","unstructured":"\"Arbeitsgruppe Sklerodermie\" der Arbeitsgemeinschaft Dermatologische Forschung (1986) Klinik der progressiven systemischen Sklerodermie (PSS). Multizentrische Untersuchung an 194 Patienten. Hautarzt 37:320\u2013324"},{"key":"0448_CR20","doi-asserted-by":"crossref","unstructured":"Campbell PM, Le Roy EC (1975) Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 4:351\u2013368","DOI":"10.1016\/0049-0172(75)90017-7"},{"key":"0448_CR21","doi-asserted-by":"crossref","unstructured":"Cantwell AR, Jones JE, Kelso DW (1984) Pleomorphic, variably acid-fast bacteria in an adult patient with disabling pansclerotic morphea. Arch Dermatol 120:656\u2013661","DOI":"10.1001\/archderm.1984.01650410098024"},{"key":"0448_CR22","doi-asserted-by":"crossref","unstructured":"Sigal M, Nahum HD, Crickx B et al. (1990) Porphyria cutanea tarda and sclerodermachance association or related disease: a case report. Clin Exp Dermatol 15:285\u2013288","DOI":"10.1111\/j.1365-2230.1990.tb02091.x"},{"key":"0448_CR23","doi-asserted-by":"crossref","unstructured":"Timonen K, Niemi KM, Mustajoki P (1991) Skin morphology in porphyria cutanea tarda does not improve despite clinical remission. Clin Exp Dermatol 16:355\u2013358","DOI":"10.1111\/j.1365-2230.1991.tb00400.x"},{"key":"0448_CR24","doi-asserted-by":"crossref","unstructured":"Friedman SJ, Doyle JA (1985) Sclerodermoid changes of porphyria cutanea tarda: possible relationship to urinary uroporphyrin levels. J Am Acad Dermatol 13:70\u201374","DOI":"10.1016\/S0190-9622(85)70145-4"},{"key":"0448_CR25","unstructured":"Simon N, Korom I, Szekers L et al. (1986) Sclerodermiform porphyria. Z Hautkr 61:1607\u20131621"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-002-0448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-002-0448-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-002-0448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-002-0448-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T08:52:34Z","timestamp":1718873554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-002-0448-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,22]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["0448"],"URL":"https:\/\/doi.org\/10.1007\/s00105-002-0448-3","relation":{},"ISSN":["0017-8470"],"issn-type":[{"value":"0017-8470","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2,22]]}}}